Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Pediatric Blood & Cancer
|
March 13, 2026
Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach
Patricia Orduña, Rose Daynielle Cansanay, Craig Erker, et al.
Nature Communications
|
November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
Melanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Acta Neuropathologica
|
June 9, 2018
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations
Christian Koelsche, Martin Mynarek, Daniel Schrimpf, et al.
Acta Neuropathologica
|
February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study
Anthony P Y Liu, Bryan K Li, Elke Pfaff, et al.
Advances in Radiation Oncology
|
December 11, 2020
Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial
Stefan Dietzsch, Felix Placzek, Klaus Pietschmann, et al.
Nature
|
May 7, 2025
Oncogene aberrations drive medulloblastoma progression, not initiation
Konstantin Okonechnikov, Piyush Joshi, Verena Körber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Martin Mynarek, Katja von Hoff, Torsten Pietsch, et al.
Acta Neuropathologica
|
January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation
Sina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Neuro-Oncology
|
September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries
Katja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Neuro-Oncology
|
April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhood
Craig Erker, Martin Mynarek, Marie Simbozel, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Pediatric Blood & Cancer
|
March 13, 2026
Group 4 Medulloblastomas of Early Childhood Treated With High-Dose Chemotherapy- and Craniospinal Irradiation-Sparing Approach
Patricia Orduña, Rose Daynielle Cansanay, Craig Erker, et al.
Nature Communications
|
November 24, 2023
Mouse models of pediatric high-grade gliomas with MYCN amplification reveal intratumoral heterogeneity and lineage signatures
Melanie Schoof, Shweta Godbole, Thomas K Albert, et al.
Acta Neuropathologica
|
June 9, 2018
Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations
Christian Koelsche, Martin Mynarek, Daniel Schrimpf, et al.
Acta Neuropathologica
|
February 23, 2021
Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study
Anthony P Y Liu, Bryan K Li, Elke Pfaff, et al.
Advances in Radiation Oncology
|
December 11, 2020
Evaluation of Prognostic Factors and Role of Participation in a Randomized Trial or a Prospective Registry in Pediatric and Adolescent Nonmetastatic Medulloblastoma - A Report From the HIT 2000 Trial
Stefan Dietzsch, Felix Placzek, Klaus Pietschmann, et al.
Nature
|
May 7, 2025
Oncogene aberrations drive medulloblastoma progression, not initiation
Konstantin Okonechnikov, Piyush Joshi, Verena Körber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 25, 2020
Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort
Martin Mynarek, Katja von Hoff, Torsten Pietsch, et al.
Acta Neuropathologica
|
January 24, 2024
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation
Sina Neyazi, Erika Yamazawa, Karoline Hack, et al.
Neuro-Oncology
|
September 30, 2025
Developing an advanced risk stratification model for pediatric intracranial ependymoma based on the prospective trial E-HIT2000 and subsequent registries
Katja von Hoff, Denise Obrecht-Sturm, David R Ghasemi, et al.
Neuro-Oncology
|
April 5, 2025
Salvage therapies for first relapse of SHH medulloblastoma in early childhood
Craig Erker, Martin Mynarek, Marie Simbozel, et al.
Page
of 10